Focus On Metabolism · "Bacteria" Balance In Blood Pressure, Blood Lipids, Blood Sugar And Uric Acid丨bioyitech Participated In The 19th Probiotics Symposium
On May 22-24, the 19th International Symposium on Probiotics And Health took place in Guangzhou, Guangdong Province. Experts discussed global probiotic science and technology trends and proposed ideas to enhance productivity in the industry through innovation. Strengthening collaboration between science, technology, and the industry is crucial for adding more value to the probiotic sector.
During the symposium, around 80 excellent presentations showcased the latest scientific and technological advancements in global probiotics and industrial innovation. Prof. Lanwei Zhang, Executive Director of the LactoBacillus Branch of the Chinese Food Society, and other distinguished professors led the event.
At this symposium, the organizers have designated 5 specific topics: Biological Characteristics of Probiotics and Prebiotics and Host Health, Research on Probiotics Mechanisms and Industrial Technological Innovation, Scientific Evidence on Probiotics, Prebiotics and Early Life Health, Scientific Research and Industrial Practice on Probiotics and Gut-Brain Axis, and Frontiers of Research on Postbiotics and their Health Mechanisms.
Bioyitech was also extended an invitation to participate in the exhibition and was provided with a specialized booth at B5 of the main venue to engage in in-depth technical discussions and exchanges with the academic experts and industry leaders present at the conference.
Bioyitech specializes in functional probiotics to address contemporary metabolic disorders, with a focus on the burgeoning metabolic issues seen in younger populations.
The company centers its research on the "sugar-lipid-acid" metabolism field, delving into genetic-level exploration. Their approach involves leveraging probiotics to enhance the body's internal "metabolism power," aiming to harmonize and regulate overall body health. Bioyitech's enduring commitment lies in advancing evidence-based practices through ongoing research on functional strain selection and properties for effective metabolic management.
In a symposium sub-forum, Dr. Maozhen Zhao presented Bioyitech's recent research on probiotics to address obesity. The study explores using Bile Salt Hydrolase Probiotics combined with Fucoidan to regulate Bile Enzyme Metabolism for obesity management, offering a novel intervention approach for the global obesity issue.
